The present invention relates to the regulation of the activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity. The invention further relates to methods of screening for agonists or antagonists of NET in order to identify new pro-angiogenic or anti-angiogenic compounds and to therapeutic uses of these compounds. The invention also relates to transgenic animals bearing mutations in NET gene.
申请公布号
WO0235235(A3)
申请公布日期
2002.11.28
申请号
WO2001EP12987
申请日期
2001.10.23
申请人
AVENTIS PHARMA S.A.;INSERM;WASYLYK, BOHDAN;MULTON, MARIE-CHRISTINE;AYADI, ABDELKADER;ZHENG, HONG
发明人
WASYLYK, BOHDAN;MULTON, MARIE-CHRISTINE;AYADI, ABDELKADER;ZHENG, HONG